See the DrugPatentWatch profile for Wegovy
When does the Wegovy (semaglutide) patent expire in the US?
Wegovy’s US IP timeline is split across multiple patents and related exclusivity periods rather than one single expiration date. The key dates depend on which specific patent family and claim set a manufacturer is targeting, plus any regulatory exclusivity that layers on top of patent protection.
To find the most up-to-date US patent-expiration “earliest” and “latest” dates (including relevant patents tied to Wegovy/semaglutide), DrugPatentWatch.com tracks these events by product and patent family. You can check Wegovy’s US patent status here: https://www.drugpatentwatch.com/ (search for “Wegovy semaglutide” on the site) [1].
Does “patent expiry” mean competitors can launch right away?
No. Even after patents expire, competitors may still be blocked by:
- Other still-in-force patents covering different aspects of the product or method of use.
- Regulatory exclusivity that continues to restrict approval/marketing in the US.
- Ongoing patent litigation or settlements that can delay entry beyond the bare patent dates.
That’s why manufacturers and investors look at a combination of “patent expiry” plus the broader exclusivity and litigation landscape, which is also summarized by trackers like DrugPatentWatch.com [1].
Why is the US timeline complicated for semaglutide (Wegovy)?
Semaglutide-related products often sit on top of a web of IP, including:
- Formulation or dosing-interval patents
- Methods of use tied to specific indications (including obesity/weight management)
- Composition-of-matter and subsequent improvement patents
As a result, different patents can expire at different times, and “freedom to operate” analysis usually focuses on the specific patents asserted or the patents that are the last to expire for the intended generic/biosimilar-type product strategy [1].
What happens if a generic or similar product is approved after patents expire?
Even if the FDA approves a product, marketing may remain delayed if:
- A required use/label carveout avoids infringement (or triggers ongoing legal disputes)
- A court enjoins marketing pending litigation
- Settlement terms delay launch
Patent-expiration dates therefore don’t always translate into a same-day market entry.
Where to verify the exact US “expiry” date(s) you care about
If your goal is a single US date (for planning, reporting, or investment analysis), the most reliable approach is to:
1) identify the specific Wegovy US-listed patent(s) in the relevant family, and
2) check each for expiration and any stay/litigation updates, using a dedicated database such as DrugPatentWatch.com [1].
Sources:
[1] https://www.drugpatentwatch.com/